Related Experiment Videos
A validation study of the Siriraj Stroke Score
Abstract:
A cross-sectional study was conducted on 160 Malaysian patients to validate the usefulness of the Siriraj Stroke Score (SSS) for differentiating intracerebral haemorrhage and infarction following acute strokes. Our results indicate that the score lacks sensitivity and specificity. It should thus not be used in epidemiological studies to determine stroke types in a community. More importantly, in the absence of information from neuroimaging of the brain, it cannot be used safely by physicians to assess the need or otherwise of thrombolytic and/or anticoagulant therapy after an acute stroke.
Insights
The Siriraj Stroke Score (SSS) is not reliable for distinguishing stroke types in Malaysia. Physicians should not use the SSS alone to guide acute stroke treatment decisions.
Area of Science:
- Neurology
- Clinical Medicine
Background:
- Acute stroke diagnosis relies on differentiating between ischemic and hemorrhagic events.
- Accurate stroke classification is crucial for appropriate treatment selection, including thrombolytic and anticoagulant therapies.
- The Siriraj Stroke Score (SSS) has been proposed as a clinical tool for rapid stroke type differentiation.
Purpose of the Study:
- To validate the clinical usefulness of the Siriraj Stroke Score (SSS) in a Malaysian population.
- To assess the SSS's accuracy in differentiating between intracerebral hemorrhage and infarction in acute stroke patients.
- To determine the SSS's suitability for epidemiological studies and clinical decision-making in acute stroke management.
Main Methods:
- A cross-sectional study involving 160 Malaysian patients with acute stroke.
- Validation of the Siriraj Stroke Score (SSS) against confirmed stroke diagnoses.
- Analysis of the SSS's sensitivity and specificity for identifying stroke subtypes.
Main Results:
- The Siriraj Stroke Score (SSS) demonstrated low sensitivity and specificity in differentiating intracerebral hemorrhage from infarction.
- The study found the SSS to be inadequate for reliable stroke type determination in the studied population.
- Results indicate significant limitations in using the SSS for epidemiological assessments of stroke subtypes.
Conclusions:
- The Siriraj Stroke Score (SSS) is not recommended for epidemiological studies to determine stroke types in the community.
- Physicians should not rely solely on the SSS for assessing the need for thrombolytic or anticoagulant therapy in acute stroke patients, especially without neuroimaging.
- Clinical decision-making for acute stroke management requires more definitive diagnostic methods than the SSS.